Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118469) titled 'The application of taVNS for neuroprotective therapy in patients with sepsis-associated encephalopathy' on Feb. 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Sepsis-associated encephalopathy
Intervention:
taVNS group:Transcutaneous auricular vagus nerve stimulation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-06
Target Sample Size: taVNS group:30;Sham stimulation group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=2...